146 related articles for article (PubMed ID: 22587628)
1. Increased risk of ovarian hyperstimulation syndrome following controlled ovarian hyperstimulation in patients with vascular endothelial growth factor +405 cc genotype.
Hanevik HI; Hilmarsen HT; Skjelbred CF; Tanbo T; Kahn JA
Gynecol Endocrinol; 2012 Nov; 28(11):845-9. PubMed ID: 22587628
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)-a retrospective case-control study.
Nouri K; Haslinger P; Szabo L; Sator M; Schreiber M; Schneeberger C; Pietrowski D
J Ovarian Res; 2014; 7():54. PubMed ID: 24851136
[TBL] [Abstract][Full Text] [Related]
3. Kinase insert domain receptor/vascular endothelial growth factor receptor 2 (KDR) genetic variation is associated with ovarian hyperstimulation syndrome.
O'Brien TJ; Harralson AF; Tran T; Gindoff I; Orkunoglu-Suer FE; Frankfurter D; Gindoff P
Reprod Biol Endocrinol; 2014 May; 12():36. PubMed ID: 24886133
[TBL] [Abstract][Full Text] [Related]
4. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.
Pietrowski D; Szabo L; Sator M; Just A; Egarter C
Hum Reprod; 2012 Jan; 27(1):196-9. PubMed ID: 22016416
[TBL] [Abstract][Full Text] [Related]
5. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model.
Gomez R; Gonzalez-Izquierdo M; Zimmermann RC; Novella-Maestre E; Alonso-Muriel I; Sanchez-Criado J; Remohi J; Simon C; Pellicer A
Endocrinology; 2006 Nov; 147(11):5400-11. PubMed ID: 16901966
[TBL] [Abstract][Full Text] [Related]
6. Physiology and pathology of ovarian hyperstimulation syndrome.
Gómez R; Soares SR; Busso C; Garcia-Velasco JA; Simón C; Pellicer A
Semin Reprod Med; 2010 Nov; 28(6):448-57. PubMed ID: 21082502
[TBL] [Abstract][Full Text] [Related]
7. Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways.
Chen SU; Chou CH; Lin CW; Lee H; Wu JC; Lu HF; Chen CD; Yang YS
Hum Reprod; 2010 Mar; 25(3):757-67. PubMed ID: 20008399
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
Pau E; Alonso-Muriel I; Gómez R; Novella E; Ruiz A; García-Velasco JA; Simón C; Pellicer A
Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
[TBL] [Abstract][Full Text] [Related]
9. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome.
Kobayashi H; Okada Y; Asahina T; Gotoh J; Terao T
J Mol Endocrinol; 1998 Jun; 20(3):363-74. PubMed ID: 9687159
[TBL] [Abstract][Full Text] [Related]
10. A single nucleotide polymorphism in BMP15 is associated with high response to ovarian stimulation.
Hanevik HI; Hilmarsen HT; Skjelbred CF; Tanbo T; Kahn JA
Reprod Biomed Online; 2011 Jul; 23(1):97-104. PubMed ID: 21565556
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 15 (BMP15) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (OHSS).
Morón FJ; de Castro F; Royo JL; Montoro L; Mira E; Sáez ME; Real LM; González A; Mañes S; Ruiz A
Pharmacogenet Genomics; 2006 Jul; 16(7):485-95. PubMed ID: 16788381
[TBL] [Abstract][Full Text] [Related]
12. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
[TBL] [Abstract][Full Text] [Related]
13. Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome.
Tong XM; Zhang SY; Song T; Xu WH; Lin XN; Shu J; Liu L
Chin Med J (Engl); 2008 Dec; 121(23):2434-9. PubMed ID: 19102964
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.
Abramov Y; Barak V; Nisman B; Schenker JG
Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600
[TBL] [Abstract][Full Text] [Related]
15. Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation.
Gao MZ; Zhao XM; Sun ZG; Hong Y; Zhao LW; Zhang HQ
Fertil Steril; 2011 Feb; 95(2):673-8. PubMed ID: 21067720
[TBL] [Abstract][Full Text] [Related]
16. Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH.
Tarlatzis BC; Griesinger G; Leader A; Rombauts L; Ijzerman-Boon PC; Mannaerts BM
Reprod Biomed Online; 2012 Apr; 24(4):410-9. PubMed ID: 22386594
[TBL] [Abstract][Full Text] [Related]
17. [Ovarian hyperstimulation syndrome].
Le Gouez A; Naudin B; Grynberg M; Mercier FJ
Ann Fr Anesth Reanim; 2011 Apr; 30(4):353-62. PubMed ID: 21398079
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women.
Molskness TA; Stouffer RL; Burry KA; Gorrill MJ; Lee DM; Patton PE
Hum Reprod; 2004 Apr; 19(4):822-30. PubMed ID: 15033950
[TBL] [Abstract][Full Text] [Related]
19. [The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].
Wang Q; Yang G; Yang C; Zhan B; Yang R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):565-7. PubMed ID: 12910723
[TBL] [Abstract][Full Text] [Related]
20. Update on management of ovarian hyperstimulation syndrome.
Chen CD; Wu MY; Chao KH; Lien YR; Chen SU; Yang YS
Taiwan J Obstet Gynecol; 2011 Mar; 50(1):2-10. PubMed ID: 21482366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
